Hos 6 HIV- inficerede børn i alderen 2 til 13 år blev zidovudins plasmafarmakokinetik evalueret efter indgivelse af 120 mg/ m2 zidovudin 3 gange daglig og igen efter skift til 180 mg/ m2 2 gange daglig.
In six HIV-infected children from 2 to 13 years of age, zidovudine plasma pharmacokinetics were evaluated while subjects were receiving 120 mg/ m2 zidovudine three times daily and again after switching to 180 mg/ m2 twice daily.